Šoprek Silvija, Duvnjak Sanja, Kompes Gordan, Jurinović Luka, Tambić Andrašević Arjana
Department of Clinical Microbiology, University Hospital for Infectious Diseases "Dr. Fran Mihaljević", 10000 Zagreb, Croatia.
Laboratory for Bacterial Zoonoses and Molecular Diagnostics of Bacterial Diseases, Department for Bacteriology and Parasitology, Croatian Veterinary Institute, 10000 Zagreb, Croatia.
Microorganisms. 2022 Jul 13;10(7):1410. doi: 10.3390/microorganisms10071410.
Campylobacteriosis represents a global health challenge due to continuously increasing trends of antimicrobial resistance in . can sometimes cause life-threatening and severe systematic infections (bacteremia, meningitis, and other extraintestinal infections) with very few antibiotics left as treatment options. Bearing in mind that is the predominant species in humans, in this paper, we present a study of the differences in antimicrobial resistance and genotype distribution between strains isolated from stool and primary sterile sites. We compared the genomic data obtained through whole genome sequencing (WGS) and phenotypic susceptibility data of strains. Once antimicrobial susceptibility testing of strains was carried out by the broth microdilution method for six of interest, results were compared to the identified genotypic determinants derived from WGS. The high rate of resistance to fluoroquinolones presented in this study is in accordance with national surveillance data. The proportion of strains with acquired resistance was 71% for ciprofloxacin and 20% for tetracycline. When invasive isolates were analysed separately, 40% exhibited MIC values of ciprofloxacin higher than the ECOFFs, suggesting a lower flouroquinolone resistance rate in invasive isolates. All isolates demonstrated wilde-type phenotype for chloramphenicol, erythromycin, gentamicin, and ertapenem. A special focus and review in this study was performed on a group of strains found in primary sterile samples. Apart from demonstrating a lower resistance rate, these isolates seem genetically more uniform, showing epidemiologically more homogenous patterns, which cluster to several clonal complexes, with CC49 being the most represented clonal complex.
弯曲杆菌病是一项全球性的健康挑战,因为弯曲杆菌的抗菌药物耐药性呈持续上升趋势。弯曲杆菌有时会导致危及生命的严重全身性感染(菌血症、脑膜炎和其他肠外感染),而可供治疗选择的抗生素所剩无几。鉴于空肠弯曲杆菌是人类感染中的主要菌种,在本文中,我们展示了一项关于从粪便和原发性无菌部位分离出的菌株之间抗菌药物耐药性和基因型分布差异的研究。我们比较了通过全基因组测序(WGS)获得的基因组数据和弯曲杆菌菌株的表型药敏数据。一旦通过肉汤微量稀释法对六种目标弯曲杆菌菌株进行了药敏试验,就将结果与从WGS中确定的基因型决定因素进行比较。本研究中呈现的对氟喹诺酮类药物的高耐药率与国家监测数据一致。获得性耐药菌株的比例,环丙沙星为71%,四环素为20%。当单独分析侵袭性分离株时,40%的环丙沙星MIC值高于ECOFFs,表明侵袭性分离株的氟喹诺酮耐药率较低。所有分离株对氯霉素、红霉素、庆大霉素和厄他培南均表现出野生型表型。本研究特别关注并回顾了在原发性无菌样本中发现的一组弯曲杆菌菌株。除了显示出较低的耐药率外,这些分离株在基因上似乎更一致,在流行病学上表现出更均匀的模式,聚集为几个克隆复合体,其中CC49是最具代表性的克隆复合体。